Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele Li Voti

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Gastroenterology & Hepatology|January 20, 2022
Predictors of Covid-19 vaccination acceptance in IBD patients: a prospective studyAnna Viola, Marco Muscianisi, Raffaele Li Voti, et al.
Journal of Crohn'S & Colitis|September 13, 2023
Mitigating the Risk of Tofacitinib-induced Adverse Events in the Elderly Population with Ulcerative ColitisAnna Viola, Raffaele Li Voti, Chiara Bivacqua, et al.
Scandinavian Journal of Gastroenterology|December 4, 2025
Post-colectomy enteritis with ulcerative colitis: a rare but severe inflammatory conditionRaffaele Li Voti, Fabio Salvatore Macaluso, Sara Renna, et al.
Nutrients|October 29, 2025
The Role of Nutritional Therapy in the Treatment of Adults with Crohn's Disease: A ReviewRaffaele Li Voti, Fabio Salvatore Macaluso, Elena Banci, et al.
Journal of Crohn'S & Colitis|October 13, 2025
Switching to subcutaneous administration may offer more profound remission compared to intensified intravenous therapy in patients with inflammatory bowel disease and partial response following induction with intravenous vedolizumab: the PRIVEDO studyFabio Salvatore Macaluso, Walter Fries, Anna Viola, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 27, 2025
Comparative effectiveness and safety of tofacitinib and filgotinib in patients with ulcerative colitis: A propensity score-weighted cohort studyFabio Salvatore Macaluso, Walter Fries, Anna Viola, et al.
United European Gastroenterology Journal|June 20, 2026
Induction and Prolonged Induction With Mirikizumab in Ulcerative Colitis-A Prospective, Real-World Study From the Sicilian Network for Inflammatory Bowel Disease (SN-IBD)Giuseppe Costantino, Anna Viola, Andrea Iuculano, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Gastroenterology & Hepatology|January 20, 2022
Predictors of Covid-19 vaccination acceptance in IBD patients: a prospective studyAnna Viola, Marco Muscianisi, Raffaele Li Voti, et al.
Journal of Crohn'S & Colitis|September 13, 2023
Mitigating the Risk of Tofacitinib-induced Adverse Events in the Elderly Population with Ulcerative ColitisAnna Viola, Raffaele Li Voti, Chiara Bivacqua, et al.
Scandinavian Journal of Gastroenterology|December 4, 2025
Post-colectomy enteritis with ulcerative colitis: a rare but severe inflammatory conditionRaffaele Li Voti, Fabio Salvatore Macaluso, Sara Renna, et al.
Nutrients|October 29, 2025
The Role of Nutritional Therapy in the Treatment of Adults with Crohn's Disease: A ReviewRaffaele Li Voti, Fabio Salvatore Macaluso, Elena Banci, et al.
Journal of Crohn'S & Colitis|October 13, 2025
Switching to subcutaneous administration may offer more profound remission compared to intensified intravenous therapy in patients with inflammatory bowel disease and partial response following induction with intravenous vedolizumab: the PRIVEDO studyFabio Salvatore Macaluso, Walter Fries, Anna Viola, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 27, 2025
Comparative effectiveness and safety of tofacitinib and filgotinib in patients with ulcerative colitis: A propensity score-weighted cohort studyFabio Salvatore Macaluso, Walter Fries, Anna Viola, et al.
United European Gastroenterology Journal|June 20, 2026
Induction and Prolonged Induction With Mirikizumab in Ulcerative Colitis-A Prospective, Real-World Study From the Sicilian Network for Inflammatory Bowel Disease (SN-IBD)Giuseppe Costantino, Anna Viola, Andrea Iuculano, et al.
Pageof 1